ENDRA Life Sciences Inc. (NDRA) stock
NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)
Close on Nov 18, 2026Market cap $6.05MP/E –Yield –
ENDRA Life Sciences gross margin
Gross margin is gross profit as a percentage of revenue.
ENDRA Life Sciences's gross margin for the twelve months ending Dec 31, 2018 was 100.0%. For fiscal 2018 it was 100.0%, against 50.9% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | 100.0% | +49.1 |
| FY2017 | Dec 31, 2017 | 50.9% | −3.4 |
| FY2016 | Dec 31, 2016 | 54.3% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2018 | Mar 31, 2018 | 100.0% | +45.7 |
| Q4 FY2017 | Dec 31, 2017 | 55.0% | – |
| Q3 FY2017 | Sep 30, 2017 | 58.8% | – |
| Q2 FY2017 | Jun 30, 2017 | 11.0% | – |
| Q4 FY2016 | Dec 31, 2016 | 54.3% | – |
See a number that looks wrong?